aTYR PHARMA (ATYR) Amortization of Deferred Charges (2019 - 2021)
aTYR PHARMA's Amortization of Deferred Charges history spans 3 years, with the latest figure at $212000.0 for Q4 2021.
- For Q4 2021, Amortization of Deferred Charges rose 79.66% year-over-year to $212000.0; the TTM value through Dec 2021 reached $829000.0, up 18.94%, while the annual FY2021 figure was $829000.0, 18.94% up from the prior year.
- Amortization of Deferred Charges reached $212000.0 in Q4 2021 per ATYR's latest filing, up from $206000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $235000.0 in Q2 2021 to a low of $118000.0 in Q4 2020.
- Average Amortization of Deferred Charges over 3 years is $188083.3, with a median of $191000.0 recorded in 2019.
- Peak YoY movement for Amortization of Deferred Charges: plummeted 39.49% in 2020, then surged 79.66% in 2021.
- A 3-year view of Amortization of Deferred Charges shows it stood at $195000.0 in 2019, then tumbled by 39.49% to $118000.0 in 2020, then soared by 79.66% to $212000.0 in 2021.
- Per Business Quant, the three most recent readings for ATYR's Amortization of Deferred Charges are $212000.0 (Q4 2021), $206000.0 (Q3 2021), and $235000.0 (Q2 2021).